Francheska Colón‐González

768 citations

19 papers · 596 indexed · h-index 12

Co-authors: Marcelo G. Kazanietz Jieru E. Lin Scott A. Waldman Gilbert W. Kim Michael Valentino Walter K. Kraft Dennis E. Discher Thomas D. Dziubla
Topics: Antibiotics Pharmacokinetics and Efficacy (5 papers)Antibiotic Resistance in Bacteria (3 papers)Regulation of Appetite and Obesity (3 papers)
Cited by: Applied Microbiology and Biotechnology Molecular Medicine Endocrine and Autonomic Systems
Journals: Journal of Biological Chemistry Nature Communications Cancer Research
Partner nations: United States China Netherlands

In The Last Decade

Francheska Colón‐González

18 papers receiving 584 citations

Peers

Countries citing papers authored by Francheska Colón‐González

Since Specialization

Citations

This map shows the geographic impact of Francheska Colón‐González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francheska Colón‐González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francheska Colón‐González more than expected).

Fields of papers citing papers by Francheska Colón‐González

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francheska Colón‐González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francheska Colón‐González. The network helps show where Francheska Colón‐González may publish in the future.

Co-authorship network of co-authors of Francheska Colón‐González

This figure shows the co-authorship network connecting the top 25 collaborators of Francheska Colón‐González. A scholar is included among the top collaborators of Francheska Colón‐González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francheska Colón‐González. Francheska Colón‐González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	A single- and multiple-dose study to characterize the pharmacokinetics, safety, and tolerability of ceftolozane/tazobactam in healthy Chinese participants 2023 ·International Journal of Antimicrobial Agents ·Na Liu,Xiaohong Wang,Jixiang Zhu,Sumit Basu,Yudong Wei,(unknown),Hui Wang,Francheska Colón‐González,Hwa-ping Feng,(unknown),Haiyan Li,(unknown)	2
2	Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy Participants 2020 ·Clinical Pharmacology in Drug Development ·(unknown),Yang Liu,(unknown),Terry O’Reilly,Francheska Colón‐González,Evan Friedman,Mallika Lala,Elizabeth G. Rhee,Matthew L. Rizk	3
3	A Single- and Multiple-Dose Study To Characterize the Pharmacokinetics, Safety, and Tolerability of Imipenem and Relebactam in Healthy Chinese Participants 2020 ·Antimicrobial Agents and Chemotherapy ·Xiaohong Wang,Na Liu,Yudong Wei,Shuang Zhang,Haiyan Li,(unknown),Munjal Patel,Hui Wang,(unknown),Francheska Colón‐González,(unknown),(unknown)	0
4	Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults 2020 ·Clinical and Translational Science ·(unknown),Walter K. Kraft,(unknown),Francheska Colón‐González,Wen Liu,Jialin Xu,Deborah Panebianco,Lori Mixson,Marissa F. Dockendorf,Catherine Z. Matthews,Ramesh Boinpally	26
5	Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin 2019 ·British Journal of Clinical Pharmacology ·(unknown),Francheska Colón‐González,Yang Liu,Jin Wu,Shiyao Xu,(unknown),Patricia Jumes,Kenneth C. Lasseter,Thomas Marbury,Matthew L. Rizk,Mallika Lala,Elizabeth G. Rhee,Joan R. Butterton,(unknown)	11
6	Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants 2018 ·Antimicrobial Agents and Chemotherapy ·Elizabeth G. Rhee,Matthew L. Rizk,Nicole Calder,(unknown),Steve Warrington,Michael S. Schwartz,Eric Mangin,(unknown),(unknown),Francheska Colón‐González,Patricia Jumes,Yang Liu,Joan R. Butterton	42
7	Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin–GUCY2C Paracrine Signaling Axis 2016 ·Cancer Research ·Jieru E. Lin,Francheska Colón‐González,Erik Blomain,Gilbert W. Kim,(unknown),(unknown),(unknown),Adam E. Snook,Tingting Zhan,Terry Hyslop,Michal Tomczak,Richard S. Blumberg,Scott A. Waldman	47
8	Abstract 2882: Calorie-induced silencing of the tumor suppressive guanylin-GUCY2C paracrine axis underlies colorectal cancer in obesity 2015 ·Cancer Research ·Erik Blomain,Jieru E. Lin,Francheska Colón‐González,Gilbert W. Kim,Terry Hyslop,Tingting Zhan,Adam E. Snook,Scott A. Waldman	1
9	No Evidence of a Drug-Drug Interaction Between Letermovir (MK-8228) and Mycophenolate Mofetil 2015 ·Biology of Blood and Marrow Transplantation ·William L. Marshall,Cyrus Badshah,(unknown),Walter K. Kraft,Francheska Colón‐González,Arne van Schanke,(unknown),Bhavna Kantesaria,Ellen G. J. Hulskotte,(unknown),Joan R. Butterton,Eugene E. Marcantonio	2
10	Coordinated activation of the Rac-GAP β2-chimaerin by an atypical proline-rich domain and diacylglycerol 2013 ·Nature Communications ·Álvaro Gutiérrez-Uzquiza,Francheska Colón‐González,Thomas A. Leonard,Bertram Canagarajah,Hongbin Wang,Bruce J. Mayer,James H. Hurley,Marcelo G. Kazanietz	11
11	GUCY2C at the intersection of obesity and colorectal cancer 2013 ·BMC Pharmacology and Toxicology ·Scott A. Waldman,Jieru E. Lin,Francheska Colón‐González,Adam E. Snook,Michael Valentino,Gilbert Kim,Erik Blomain,Terry Hyslop	2
12	Obesity pharmacotherapy: What is next? 2012 ·Molecular Aspects of Medicine ·Francheska Colón‐González,Gilbert W. Kim,Jieru E. Lin,Michael Valentino,Scott A. Waldman	47
13	Regulation of appetite to treat obesity 2011 ·Expert Review of Clinical Pharmacology ·Gilbert W. Kim,Jieru E. Lin,Michael Valentino,Francheska Colón‐González,Scott A. Waldman	35
14	Pharmacokinetic evaluation of fosaprepitant dimeglumine 2010 ·Expert Opinion on Drug Metabolism & Toxicology ·Francheska Colón‐González,Walter K. Kraft	24
15	Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity 2010 ·Expert Review of Endocrinology & Metabolism ·Michael Valentino,Francheska Colón‐González,Jieru E. Lin,Scott A. Waldman	2
16	A Novel Cross-talk in Diacylglycerol Signaling 2010 ·Journal of Biological Chemistry ·Erin Griner,M. Cecilia Caino,María Soledad Sosa,Francheska Colón‐González,Michael J. Chalmers,Harald Mischak,Marcelo G. Kazanietz	17
17	Identification of an Autoinhibitory Mechanism That Restricts C1 Domain-mediated Activation of the Rac-GAP α2-Chimaerin 2008 ·Journal of Biological Chemistry ·Francheska Colón‐González,Federico Coluccio Leskow,Marcelo G. Kazanietz	23
18	Effect of Polymer Amphiphilicity on Loading of a Therapeutic Enzyme into Protective Filamentous and Spherical Polymer Nanocarriers 2007 ·Biomacromolecules ·Eric Simone,Thomas D. Dziubla,Francheska Colón‐González,Dennis E. Discher,Vladimir R. Muzykantov	45
19	C1 domains exposed: From diacylglycerol binding to protein–protein interactions 2006 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Francheska Colón‐González,Marcelo G. Kazanietz	256

About Francheska Colón‐González

Francheska Colón‐González is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Endocrine and Autonomic Systems, having authored 19 papers that have together received 596 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (3 papers) and Regulation of Appetite and Obesity (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (25 citations), Molecular Medicine (52 citations) and Endocrine and Autonomic Systems (41 citations). Francheska Colón‐González has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Marcelo G. Kazanietz, Jieru E. Lin, Scott A. Waldman, Gilbert W. Kim, Michael Valentino, Walter K. Kraft, Dennis E. Discher, Thomas D. Dziubla, Vladimir R. Muzykantov and Eric Simone. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact